Clinical assessment of external pressure circulatory assistance in acute myocardial infarction. Report of a cooperative clinical trial

Ezra A Amsterdam, John Banas, J. Michael Criley, Henry S. Loeb, Hiltrud Mueller, James T. Willerson, Dean T. Mason, H. Beanlands, M. Broder, M. H. Ellestad, M. Ende, S. A. Forwand, A. D. Hagan, P. Lavine, J. V. Messer, J. Morch, T. Nivatpumin, A. Obeid, E. Perlstein, S. H. RahimtoolaE. Rapaport, I. Schatz, J. Schroeder, S. Smith, W. Towne, W. Tuttle

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The clinical effects of early application of external pressure circulatory assistance (EPCA) in acute myocardial infarction were evaluated in a prospective, randomized trial involving 258 patients in 25 institutions. All patients had mild left ventricular failure and received circulatory assistance within the first 24 hours after the onset of symptoms. There were no significant differences between the treatment and control groups, consisting of 142 patients and 116 patients, respectively, with regard to age, sex, race, previous cardiac history, electrocardiographic location of myocardial infarction, Norris prognostic index, admission heart rate, blood pressure and chest roentgenogram, and time from onset of symptoms to hospital admission. There were also no differences between the treatment and control groups with regard to antiarrhythmic, positive inotropic, diuretic and vasodilator therapy. Hospital mortality was significantly decreased, compared with that of control patients, in the group receiving 4 or more hours of external pressure circulatory assistance within the first 24 hours after admission (mortality rate 6.5 percent [7 of 108] in treatment group versus 14.7 percent [17 of 116] in control group, p < 0.05). Circulatory assistance for 3 or more hours was also associated with a lower mortality rate in the subgroup (patients 46 or more years old) to which mortality in this study was confined (mortality rate 8.3 percent [9 of 109] in the treatment group versus 17.5 percent [17 of 97] in the control group, p < 0.05). For the combined group of patients with 3 or more and 4 or more hours of treatment, circulatory assistance was associated with significant lessening (p < 0.05 to < 0.01) of morbidity as manifested by recurrent chest pain, progression of cardiac failure, occurrence of ventricular fibrillation, change in heart size and clinical cardiac functional status at discharge. These data support further application and investigation of external pressure circulatory assistance in myocardial infarction.

Original languageEnglish (US)
Pages (from-to)349-356
Number of pages8
JournalThe American journal of cardiology
Volume45
Issue number2
DOIs
StatePublished - 1980

Fingerprint

Myocardial Infarction
Clinical Trials
Pressure
Control Groups
Mortality
Therapeutics
Ventricular Fibrillation
Hospital Mortality
Chest Pain
Vasodilator Agents
Diuretics
Shock
Thorax
Heart Failure
Heart Rate
History
Blood Pressure
Morbidity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Clinical assessment of external pressure circulatory assistance in acute myocardial infarction. Report of a cooperative clinical trial. / Amsterdam, Ezra A; Banas, John; Criley, J. Michael; Loeb, Henry S.; Mueller, Hiltrud; Willerson, James T.; Mason, Dean T.; Beanlands, H.; Broder, M.; Ellestad, M. H.; Ende, M.; Forwand, S. A.; Hagan, A. D.; Lavine, P.; Messer, J. V.; Morch, J.; Nivatpumin, T.; Obeid, A.; Perlstein, E.; Rahimtoola, S. H.; Rapaport, E.; Schatz, I.; Schroeder, J.; Smith, S.; Towne, W.; Tuttle, W.

In: The American journal of cardiology, Vol. 45, No. 2, 1980, p. 349-356.

Research output: Contribution to journalArticle

Amsterdam, EA, Banas, J, Criley, JM, Loeb, HS, Mueller, H, Willerson, JT, Mason, DT, Beanlands, H, Broder, M, Ellestad, MH, Ende, M, Forwand, SA, Hagan, AD, Lavine, P, Messer, JV, Morch, J, Nivatpumin, T, Obeid, A, Perlstein, E, Rahimtoola, SH, Rapaport, E, Schatz, I, Schroeder, J, Smith, S, Towne, W & Tuttle, W 1980, 'Clinical assessment of external pressure circulatory assistance in acute myocardial infarction. Report of a cooperative clinical trial', The American journal of cardiology, vol. 45, no. 2, pp. 349-356. https://doi.org/10.1016/0002-9149(80)90658-X
Amsterdam, Ezra A ; Banas, John ; Criley, J. Michael ; Loeb, Henry S. ; Mueller, Hiltrud ; Willerson, James T. ; Mason, Dean T. ; Beanlands, H. ; Broder, M. ; Ellestad, M. H. ; Ende, M. ; Forwand, S. A. ; Hagan, A. D. ; Lavine, P. ; Messer, J. V. ; Morch, J. ; Nivatpumin, T. ; Obeid, A. ; Perlstein, E. ; Rahimtoola, S. H. ; Rapaport, E. ; Schatz, I. ; Schroeder, J. ; Smith, S. ; Towne, W. ; Tuttle, W. / Clinical assessment of external pressure circulatory assistance in acute myocardial infarction. Report of a cooperative clinical trial. In: The American journal of cardiology. 1980 ; Vol. 45, No. 2. pp. 349-356.
@article{22d26db7db0a479981ce549c7825e94b,
title = "Clinical assessment of external pressure circulatory assistance in acute myocardial infarction. Report of a cooperative clinical trial",
abstract = "The clinical effects of early application of external pressure circulatory assistance (EPCA) in acute myocardial infarction were evaluated in a prospective, randomized trial involving 258 patients in 25 institutions. All patients had mild left ventricular failure and received circulatory assistance within the first 24 hours after the onset of symptoms. There were no significant differences between the treatment and control groups, consisting of 142 patients and 116 patients, respectively, with regard to age, sex, race, previous cardiac history, electrocardiographic location of myocardial infarction, Norris prognostic index, admission heart rate, blood pressure and chest roentgenogram, and time from onset of symptoms to hospital admission. There were also no differences between the treatment and control groups with regard to antiarrhythmic, positive inotropic, diuretic and vasodilator therapy. Hospital mortality was significantly decreased, compared with that of control patients, in the group receiving 4 or more hours of external pressure circulatory assistance within the first 24 hours after admission (mortality rate 6.5 percent [7 of 108] in treatment group versus 14.7 percent [17 of 116] in control group, p < 0.05). Circulatory assistance for 3 or more hours was also associated with a lower mortality rate in the subgroup (patients 46 or more years old) to which mortality in this study was confined (mortality rate 8.3 percent [9 of 109] in the treatment group versus 17.5 percent [17 of 97] in the control group, p < 0.05). For the combined group of patients with 3 or more and 4 or more hours of treatment, circulatory assistance was associated with significant lessening (p < 0.05 to < 0.01) of morbidity as manifested by recurrent chest pain, progression of cardiac failure, occurrence of ventricular fibrillation, change in heart size and clinical cardiac functional status at discharge. These data support further application and investigation of external pressure circulatory assistance in myocardial infarction.",
author = "Amsterdam, {Ezra A} and John Banas and Criley, {J. Michael} and Loeb, {Henry S.} and Hiltrud Mueller and Willerson, {James T.} and Mason, {Dean T.} and H. Beanlands and M. Broder and Ellestad, {M. H.} and M. Ende and Forwand, {S. A.} and Hagan, {A. D.} and P. Lavine and Messer, {J. V.} and J. Morch and T. Nivatpumin and A. Obeid and E. Perlstein and Rahimtoola, {S. H.} and E. Rapaport and I. Schatz and J. Schroeder and S. Smith and W. Towne and W. Tuttle",
year = "1980",
doi = "10.1016/0002-9149(80)90658-X",
language = "English (US)",
volume = "45",
pages = "349--356",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Clinical assessment of external pressure circulatory assistance in acute myocardial infarction. Report of a cooperative clinical trial

AU - Amsterdam, Ezra A

AU - Banas, John

AU - Criley, J. Michael

AU - Loeb, Henry S.

AU - Mueller, Hiltrud

AU - Willerson, James T.

AU - Mason, Dean T.

AU - Beanlands, H.

AU - Broder, M.

AU - Ellestad, M. H.

AU - Ende, M.

AU - Forwand, S. A.

AU - Hagan, A. D.

AU - Lavine, P.

AU - Messer, J. V.

AU - Morch, J.

AU - Nivatpumin, T.

AU - Obeid, A.

AU - Perlstein, E.

AU - Rahimtoola, S. H.

AU - Rapaport, E.

AU - Schatz, I.

AU - Schroeder, J.

AU - Smith, S.

AU - Towne, W.

AU - Tuttle, W.

PY - 1980

Y1 - 1980

N2 - The clinical effects of early application of external pressure circulatory assistance (EPCA) in acute myocardial infarction were evaluated in a prospective, randomized trial involving 258 patients in 25 institutions. All patients had mild left ventricular failure and received circulatory assistance within the first 24 hours after the onset of symptoms. There were no significant differences between the treatment and control groups, consisting of 142 patients and 116 patients, respectively, with regard to age, sex, race, previous cardiac history, electrocardiographic location of myocardial infarction, Norris prognostic index, admission heart rate, blood pressure and chest roentgenogram, and time from onset of symptoms to hospital admission. There were also no differences between the treatment and control groups with regard to antiarrhythmic, positive inotropic, diuretic and vasodilator therapy. Hospital mortality was significantly decreased, compared with that of control patients, in the group receiving 4 or more hours of external pressure circulatory assistance within the first 24 hours after admission (mortality rate 6.5 percent [7 of 108] in treatment group versus 14.7 percent [17 of 116] in control group, p < 0.05). Circulatory assistance for 3 or more hours was also associated with a lower mortality rate in the subgroup (patients 46 or more years old) to which mortality in this study was confined (mortality rate 8.3 percent [9 of 109] in the treatment group versus 17.5 percent [17 of 97] in the control group, p < 0.05). For the combined group of patients with 3 or more and 4 or more hours of treatment, circulatory assistance was associated with significant lessening (p < 0.05 to < 0.01) of morbidity as manifested by recurrent chest pain, progression of cardiac failure, occurrence of ventricular fibrillation, change in heart size and clinical cardiac functional status at discharge. These data support further application and investigation of external pressure circulatory assistance in myocardial infarction.

AB - The clinical effects of early application of external pressure circulatory assistance (EPCA) in acute myocardial infarction were evaluated in a prospective, randomized trial involving 258 patients in 25 institutions. All patients had mild left ventricular failure and received circulatory assistance within the first 24 hours after the onset of symptoms. There were no significant differences between the treatment and control groups, consisting of 142 patients and 116 patients, respectively, with regard to age, sex, race, previous cardiac history, electrocardiographic location of myocardial infarction, Norris prognostic index, admission heart rate, blood pressure and chest roentgenogram, and time from onset of symptoms to hospital admission. There were also no differences between the treatment and control groups with regard to antiarrhythmic, positive inotropic, diuretic and vasodilator therapy. Hospital mortality was significantly decreased, compared with that of control patients, in the group receiving 4 or more hours of external pressure circulatory assistance within the first 24 hours after admission (mortality rate 6.5 percent [7 of 108] in treatment group versus 14.7 percent [17 of 116] in control group, p < 0.05). Circulatory assistance for 3 or more hours was also associated with a lower mortality rate in the subgroup (patients 46 or more years old) to which mortality in this study was confined (mortality rate 8.3 percent [9 of 109] in the treatment group versus 17.5 percent [17 of 97] in the control group, p < 0.05). For the combined group of patients with 3 or more and 4 or more hours of treatment, circulatory assistance was associated with significant lessening (p < 0.05 to < 0.01) of morbidity as manifested by recurrent chest pain, progression of cardiac failure, occurrence of ventricular fibrillation, change in heart size and clinical cardiac functional status at discharge. These data support further application and investigation of external pressure circulatory assistance in myocardial infarction.

UR - http://www.scopus.com/inward/record.url?scp=0018835686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018835686&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(80)90658-X

DO - 10.1016/0002-9149(80)90658-X

M3 - Article

C2 - 6986746

AN - SCOPUS:0018835686

VL - 45

SP - 349

EP - 356

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 2

ER -